|
1
|
Park YJ, Kong HJ, Jang HC, Shin HS, Oh HK
and Park JS: Malignant mesothelioma of the spermatic cord. Korean J
Urol. 52:225–229. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shimada S, Ono K, Suzuki Y and Mori N:
Malignant mesothelioma of the tunica vaginalis testis: A case with
a predominant sarcomatous component. Pathol Int. 54:930–934. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen JL and Hsu YH: Malignant mesothelioma
of the tunica vaginalis testis: A case report and literature
review. Kaohsiung J Med Sci. 25:77–81. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Antman K, Hassan R, Eisner M, Ries LA and
Edwards BK: Update on malignant mesothelioma. Oncology (Williston
Park). 19(1301–1310): 1313–1316. 2005.
|
|
5
|
Murai Y: Malignant mesothelioma in Japan:
Analysis of registered autopsy cases. Arch Environ Health.
56:84–88. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Plas E, Riedl CR and Pflüger H: Malignant
mesothelioma of the tunica vaginalis testis: Review of the
literature and assessment of prognostic parameters. Cancer.
83:2437–2446. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gupta NP, Agrawal AK, Sood S, Hemal AK and
Nair M: Malignant mesothelioma of the tunica vaginalis testis: A
report of two cases and review of literature. J Surg Oncol.
70:251–254. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gürdal M and Erol A: Malignant
mesothelioma of tunica vaginalis testis associated with
long-lasting hydrocele: Could hydrocele be an etiological factor?
Int Urol Nephrol. 32:687–689. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang LH, Yu JH, Xu HT, Lin XY, Liu Y, Miao
Y, Wang L, Fan CF, Jiang GY, Ding SL, et al: Mesothelioma of the
tunica vaginalis testis with prominent adenomatoid features: A case
report. Int J Clin Exp Pathol. 7:7082–7087. 2014.PubMed/NCBI
|
|
10
|
Barbera V and Rubino M: Papillary
mesothelioma of the tunica vaginalis. Cancer. 10:183–189. 1957.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Attanoos RL and Gibbs AR: Primary
malignant gonadal mesotheliomas and asbestos. Histopathology.
37:150–159. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jones MA, Young RH and Scully RE:
Malignant mesothelioma of the tunica vaginalis. A clinicopathologic
analysis of 11 cases with review of the literature. Am J Surg
Pathol. 19:815–825. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vianna NJ and Polan AK: Non-occupational
exposure to asbestos and malignant mesothelioma in females. Lancet.
1:1061–1063. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ascoli V, Cavone D, Merler E, Barbieri PG,
Romeo L, Nardi F and Musti M: Mesothelioma in blood related
subjects: Report of 11 clusters among 1954 Italy cases and review
of the literature. Am J Ind Med. 50:357–369. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Frank AL: Medical and public health
approaches to asbestos disease. Mt Sinai J Med. 62:401–405.
1995.PubMed/NCBI
|
|
16
|
McDonald JC: Health implications of
environmental exposure to asbestos. Environ Health Perspect.
62:319–328. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Merler E: Mesothelioma incidence decreases
parallel to asbestos exposure decrement or interruption: A
confirmation of a dose-response relationship, with implications in
public health. Epidemiol Prev. 31 4 Suppl 1:S46–S52. 2007.(In
Italian).
|
|
18
|
Yen CH, Lee CT, Su CJ and Lo HC: Malignant
mesothelioma of the tunica vaginalis testis: A malignancy
associated with recurrent epididymitis? World J Surg Oncol.
10:2382012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan TD, Welch L, Black D and Sugarbaker
PH: A systematic review on the efficacy of cytoreductive surgery
combined with perioperative intraperitoneal chemotherapy for
diffuse malignancy peritoneal mesothelioma. Ann Oncol. 18:827–834.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Akin Y, Bassorgun I, Basara I and Yucel S:
Malignant mesothelioma of tunica vaginalis: An extremely rare case
presenting without risk factors. Singapore Med J. 56:e53–e55. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ceresoli GL, Zucali PA, Favaretto AG,
Grossi F, Bidoli P, Del Conte G, Ceribelli A, Bearz A, Morenghi E,
Cavina R, et al: Phase II study of pemetrexed plus carboplatin in
malignant pleural mesothelioma. J Clin Oncol. 24:1443–1448. 2006.
View Article : Google Scholar : PubMed/NCBI
|
